3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial - Iveson, T; Kerr, R; Saunders, M; Cassidy, J; Hollander, N; Tabernero, J; Haydon, A; Glimelius, B; Harkin, A; Allan, K; McQueen, J; Scudder, C; et al. (Lancet Oncology, 2018)